Faeth Therapeutics, Inc.

FTHNASDAQHealthcareBiotechnology

$16.83- (-)1Y +92.16%

As of Oct 26, 2026 close

Market cap: $94.98M
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $7.45$42.14
Volume (live): -
Avg. volume (3M): 429.85K

Faeth Therapeutics, Inc. (FTH) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Faeth Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 14 professional research analysts

Consensus Rating

Buy

Based on 14 unique analysts

(16 total ratings in last 90 days)

High Confidence∞:1 Buy/Sell

Average Price Target

$57.45

+241.35% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest FTH Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 22, 2026	Patrick Trucchio	HC Wainwright	Reiterates	Buy	$60.00
Oct 16, 2026	Unknown Analyst	William Blair	Initiates	Buy	$66.00
Oct 16, 2026	Geoff Meacham	Citi	Maintains	Buy	$55.00
Oct 15, 2026	Oliver McCammon	LifeSci Capital	Initiates	Buy	$40.00
Sep 22, 2026	Patrick Trucchio	HC Wainwright	Maintains	Buy	$60.00
Sep 15, 2026	Bradley Canino	Guggenheim	Initiates	Buy	$70.00
Sep 14, 2026	Dev Prasad	Lucid Capital	Initiates	Buy	$59.00
Sep 14, 2026	Jeet Mukherjee	BTIG	Maintains	Buy	$55.00
Sep 13, 2026	Jeet Mukherjee	BTIG	Maintains	Buy	$55.00
Sep 9, 2026	Tara Bancroft	TD Cowen	Initiates	Buy	-
Aug 25, 2026	Zacks Equity Research	Zacks Equity Research	Initiates Coverage	Buy	-
Aug 21, 2026	Gil Blum	Needham	Initiates	Buy	$56.00
Aug 11, 2026	Edmund Ingham	Forbes	Initiates Coverage	Buy	-
Aug 5, 2026	Jay Olson	Oppenheimer	Maintains	Buy	$60.00
Aug 4, 2026	Boris Peaker	JonesTrading	Initiates	Buy	$55.00
Jul 31, 2026	Sean McCutcheon	Raymond James	Initiates	Buy	$56.00

Patrick Trucchio

HC Wainwright

BuyReiterates

$60.00

Oct 22

Unknown Analyst

William Blair

BuyInitiates

$66.00

Oct 16

Geoff Meacham

Citi

BuyMaintains

$55.00

Oct 16

Oliver McCammon

LifeSci Capital

BuyInitiates

$40.00

Oct 15

Patrick Trucchio

HC Wainwright

BuyMaintains

$60.00

Sep 22

Bradley Canino

Guggenheim

BuyInitiates

$70.00

Sep 15

Dev Prasad

Lucid Capital

BuyInitiates

$59.00

Sep 14

Jeet Mukherjee

BTIG

BuyMaintains

$55.00

Sep 14

Jeet Mukherjee

BTIG

BuyMaintains

$55.00

Sep 13

Tara Bancroft

TD Cowen

BuyInitiates

Sep 9

Zacks Equity Research

BuyInitiates Coverage

Aug 25

Gil Blum

Needham

BuyInitiates

$56.00

Aug 21

Edmund Ingham

Forbes

BuyInitiates Coverage

Aug 11

Jay Olson

Oppenheimer

BuyMaintains

$60.00

Aug 5

Boris Peaker

JonesTrading

BuyInitiates

$55.00

Aug 4

Sean McCutcheon

Raymond James

BuyInitiates

$56.00

Jul 31

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 22, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for FTH?

The analyst consensus rating for FTH is Buy, based on the latest ratings from 14 analysts over the last 90 days.

What is the average price target for FTH?

The average 12-month price target for FTH is $57.45, representing an upside of 241.4% from the Oct 26, 2026 close of $16.83.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.